⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30793892 | 0.83 | — | — | |
| SCHEMBL30793987 | 0.83 | CXCR4 (0.32) | — | |
| SCHEMBL30793843 | 0.83 | — | — | |
| SCHEMBL30793352 | 0.80 | HTR2A (0.32) | — | |
| SCHEMBL30793253 | 0.80 | — | — | |
| SCHEMBL24535898 | 0.77 | — | — | |
| SCHEMBL25338104 | 0.75 | PDE4A (0.34) | — | |
| SCHEMBL31460354 | 0.72 | — | — | |
| SCHEMBL30793992 | 0.71 | CHRNB2 (0.32) | — | |
| SCHEMBL30793587 | 0.70 | PDE4A (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4540254-A1 | TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS | Mirati Therapeutics, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| WO-2023244604-A1 | TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS | Mirati Therapeutics, Inc. (US) | 2023-12-21 | — | — | WO | disclosed |